|
ELAVL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.498300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.485170E-01 |
| Normal-vs-Stage2 |
8.160100E-02 |
| Normal-vs-Stage3 |
2.786500E-04 |
| Normal-vs-Stage4 |
5.016000E-01 |
| Stage1-vs-Stage2 |
3.466400E-01 |
| Stage1-vs-Stage3 |
3.055800E-03 |
| Stage1-vs-Stage4 |
6.678400E-01 |
| Stage2-vs-Stage3 |
3.570600E-01 |
| Stage2-vs-Stage4 |
3.194600E-01 |
| Stage3-vs-Stage4 |
2.146000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.574010E-02 |
| Normal-vs-AfricanAmerican |
8.240200E-01 |
| Normal-vs-Asian |
4.260400E-01 |
| Caucasian-vs-AfricanAmerican |
5.648400E-02 |
| Caucasian-vs-Asian |
2.542600E-01 |
| AfricanAmerican-vs-Asian |
4.635200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.323600E-03 |
| Normal-vs-Female |
5.371200E-01 |
| Male-vs-Female |
5.964100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.252200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.553600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.062400E-03 |
| Normal-vs-Age(81-100Yrs) |
3.790500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.160600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.730600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.807600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.863900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.643900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.071800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.623800E-01 |
| Normal-vs-Grade 2 |
1.420440E-01 |
| Normal-vs-Grade 3 |
9.556200E-03 |
| Normal-vs-Grade 4 |
1.551620E-01 |
| Grade 1-vs-Grade 2 |
2.062400E-01 |
| Grade 1-vs-Grade 3 |
5.646000E-02 |
| Grade 1-vs-Grade 4 |
2.011600E-01 |
| Grade 2-vs-Grade 3 |
8.879600E-02 |
| Grade 2-vs-Grade 4 |
6.931400E-01 |
| Grade 3-vs-Grade 4 |
4.226800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.610300E-02 |
| Normal-vs-ccB subtype |
9.809900E-02 |
| ccA subtype-vs-ccB subtype |
9.124000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.115800E-02 |
| Normal-vs-N1 |
9.615200E-01 |
| N0-vs-N1 |
3.708000E-01 |
|
|
